FDA advises on cargo, warehouse theft prevention and response

The FDA wants all drugmakers to have a plan for responding to cargo and warehouse thefts. "Swift action is essential," says the regulator in a letter to manufacturer, wholesaler, pharmacy, device and infant formula trade associations.

In yesterday's letter, acting assistant commissioner Michael Chappell writes that the FDA will determine the appropriate public health response to a theft, and that in some cases the response may even include market withdrawal for products shipped before the theft that have the same lot numbers as those stolen.

"We would like you to promptly notify FDA's Office of Criminal Investigations as soon as possible when a theft has occurred," Chappell writes.

Manufacturers have a "fundamental responsibility" to continuously review their warehouse physical security and security practices, says. And they should ensure that security practices of supply chain partners are up to snuff. "You need to be one-step ahead of thieves in securing your warehouses and product transport."

In the event of a theft, the FDA wants the victim to quickly post a notice on its website or issue a press release.

- here's the letter

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.